Harsha Thirumurthy1, Samuel H Masters2, Samwel Rao3, Megan A Bronson4, Michele Lanham5, Eunice Omanga3, Emily Evens5, Kawango Agot3. 1. Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill2Carolina Population Center, University of North Carolina at Chapel Hill. 2. Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill. 3. Impact Research and Development Organization, Kisumu, Kenya. 4. Carolina Population Center, University of North Carolina at Chapel Hill. 5. FHI 360, Durham, North Carolina.
Abstract
IMPORTANCE: Novel strategies are needed to increase the uptake of voluntary medical male circumcision (VMMC) in sub-Saharan Africa and enhance the effectiveness of male circumcision as an HIV prevention strategy. OBJECTIVE: To determine whether small economic incentives could increase circumcision prevalence by addressing reported economic barriers to VMMC and behavioral factors such as present-biased decision making. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial conducted between June 22, 2013, and February 4, 2014, among 1504 uncircumcised men aged 25 to 49 years in Nyanza region, Kenya. VMMC services were provided free of charge and participants were randomized to 1 of 3 intervention groups or a control group. INTERVENTIONS: Participants in the 3 intervention groups received varying amounts of compensation conditional on undergoing circumcision at 1 of 9 study clinics within 2 months of enrollment. Compensation took the form of food vouchers worth 200 Kenya shillings (≈ US $2.50), 700 Kenya shillings (≈ US $8.75), or 1200 Kenya shillings (≈ US $15.00), which reflected a portion of transportation costs and lost wages associated with getting circumcised. The control group received no compensation. MAIN OUTCOMES AND MEASURES: VMMC uptake within 2 months. RESULTS: Analysis of data for 1502 participants with complete data showed that VMMC uptake within 2 months was higher in the US $8.75 group (6.6%; 95% CI, 4.3%-9.5% [25 of 381]) and the US $15.00 group (9.0%; 95% CI, 6.3%-12.4% [34 of 377]) than in the US $2.50 group (1.9%; 95% CI, 0.8%-3.8% [7 of 374]) and the control group (1.6%; 95% CI, 0.6%-3.5% [6 of 370]). In logistic regression analysis, the US $8.75 group had significantly higher VMMC uptake than the control group (adjusted odds ratio [AOR] 4.3; 95% CI, 1.7-10.7), as did the US $15.00 group (AOR 6.2; 95% CI, 2.6-15.0). Effect sizes for the US $8.75 and US $15.00 groups did not differ significantly (P = .20). CONCLUSIONS AND RELEVANCE: Among uncircumcised men in Kenya, compensation in the form of food vouchers worth approximately US $8.75 or US $15.00, compared with lesser or no compensation, resulted in a modest increase in the prevalence of circumcision after 2 months. The effects of more intense promotion or longer implementation require further investigation. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01857700.
RCT Entities:
IMPORTANCE: Novel strategies are needed to increase the uptake of voluntary medical male circumcision (VMMC) in sub-Saharan Africa and enhance the effectiveness of male circumcision as an HIV prevention strategy. OBJECTIVE: To determine whether small economic incentives could increase circumcision prevalence by addressing reported economic barriers to VMMC and behavioral factors such as present-biased decision making. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial conducted between June 22, 2013, and February 4, 2014, among 1504 uncircumcised men aged 25 to 49 years in Nyanza region, Kenya. VMMC services were provided free of charge and participants were randomized to 1 of 3 intervention groups or a control group. INTERVENTIONS:Participants in the 3 intervention groups received varying amounts of compensation conditional on undergoing circumcision at 1 of 9 study clinics within 2 months of enrollment. Compensation took the form of food vouchers worth 200 Kenya shillings (≈ US $2.50), 700 Kenya shillings (≈ US $8.75), or 1200 Kenya shillings (≈ US $15.00), which reflected a portion of transportation costs and lost wages associated with getting circumcised. The control group received no compensation. MAIN OUTCOMES AND MEASURES: VMMC uptake within 2 months. RESULTS: Analysis of data for 1502 participants with complete data showed that VMMC uptake within 2 months was higher in the US $8.75 group (6.6%; 95% CI, 4.3%-9.5% [25 of 381]) and the US $15.00 group (9.0%; 95% CI, 6.3%-12.4% [34 of 377]) than in the US $2.50 group (1.9%; 95% CI, 0.8%-3.8% [7 of 374]) and the control group (1.6%; 95% CI, 0.6%-3.5% [6 of 370]). In logistic regression analysis, the US $8.75 group had significantly higher VMMC uptake than the control group (adjusted odds ratio [AOR] 4.3; 95% CI, 1.7-10.7), as did the US $15.00 group (AOR 6.2; 95% CI, 2.6-15.0). Effect sizes for the US $8.75 and US $15.00 groups did not differ significantly (P = .20). CONCLUSIONS AND RELEVANCE: Among uncircumcised men in Kenya, compensation in the form of food vouchers worth approximately US $8.75 or US $15.00, compared with lesser or no compensation, resulted in a modest increase in the prevalence of circumcision after 2 months. The effects of more intense promotion or longer implementation require further investigation. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01857700.
Authors: Jennifer S Galbraith; Athanasius Ochieng; Samuel Mwalili; Donath Emusu; Zebedee Mwandi; Andrea A Kim; George Rutherford; William K Maina; Davies O Kimanga; Kipruto Chesang; Peter Cherutich Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Damien de Walque; William H Dow; Rose Nathan; Ramadhani Abdul; Faraji Abilahi; Erick Gong; Zachary Isdahl; Julian Jamison; Boniphace Jullu; Suneeta Krishnan; Albert Majura; Edward Miguel; Jeanne Moncada; Sally Mtenga; Mathew Alexander Mwanyangala; Laura Packel; Julius Schachter; Kizito Shirima; Carol A Medlin Journal: BMJ Open Date: 2012-02-08 Impact factor: 3.006
Authors: Euphemia L Sibanda; Mary Tumushime; Juliet Mufuka; Sue Napierala Mavedzenge; Stephano Gudukeya; Sergio Bautista-Arredondo; Karin Hatzold; Harsha Thirumurthy; Sandra I McCoy; Nancy Padian; Andrew Copas; Frances M Cowan Journal: Lancet Glob Health Date: 2017-09 Impact factor: 26.763
Authors: Gabriel Chamie; Elisabeth M Schaffer; Alex Ndyabakira; Devy M Emperador; Dalsone Kwarisiima; Carol S Camlin; Diane V Havlir; James G Kahn; Moses R Kamya; Harsha Thirumurthy Journal: AIDS Date: 2018-07-17 Impact factor: 4.177
Authors: Laura M Bogart; Glenn J Wagner; William Musoke; Rose Naigino; Sebastian Linnemayr; Emily Maistrellis; David J Klein; Riana B Jumamil; Barbara Mukasa; Ingrid V Bassett; Thomas P Giordano; Rhoda K Wanyenze Journal: AIDS Behav Date: 2017-02
Authors: Kate Clouse; Constance Mongwenyana; Melda Musina; Dorah Bokaba; Lawrence Long; Mhairi Maskew; Aima Ahonkhai; Matthew P Fox Journal: AIDS Care Date: 2017-10-25
Authors: Maria A Carrasco; Jonathan M Grund; Stephanie M Davis; Renee Ridzon; Meghan Mattingly; Jessica Wilkinson; Benjamin Kasdan; Valerian Kiggundu; Emmanuel Njeuhmeli Journal: AIDS Care Date: 2018-03-22
Authors: Omar Galárraga; Sandra G Sosa-Rubí; Caroline Kuo; Pedro Gozalo; Andrea González; Biani Saavedra; Nathalie Gras-Allain; Carlos J Conde-Glez; Maria Olamendi-Portugal; Kenneth H Mayer; Don Operario Journal: AIDS Behav Date: 2017-12
Authors: Gideon Amanyire; Fred C Semitala; Jennifer Namusobya; Richard Katuramu; Leatitia Kampiire; Jeanna Wallenta; Edwin Charlebois; Carol Camlin; James Kahn; Wei Chang; David Glidden; Moses Kamya; Diane Havlir; Elvin Geng Journal: Lancet HIV Date: 2016-08-27 Impact factor: 12.767